Case Studies in Breast Cancer Vol. 6, No. 2
Release Date: August 20, 2008
Expiration Date: August 20, 2009
Incorporating Antiangiogenic Therapy Into First-line Treatment of HER2-Negative Metastatic Breast Cancer
Erica Mayer, MD, MPH
Read all of the conditions in the Activity Terms box below. You must accept the Activity Terms in order to continue:
Disclosure Policy
It is the policy of Physicians' Education Resource to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Physicians' Education Resource requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest. Physicians' Education Resource has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity.
Erica Mayer, MD, MPH
No relevant relationships to disclose
PER Editorial Staff
No relevant relationships to disclose
This CME activity might include discussion of investigational and/or unlabeled uses of drugs. If the activity includes discussion of investigational and/or unlabeled uses of a drug, specific information is located on the title page. Please refer to the full prescribing information for each drug discussed in this newsletter for FDA–approved dosing, indications, and warnings.
Commercial Support
An educational grant for this activity was provided by Genentech BioOncology.
Software Requirements
The Web pages and Web–based applications require a minimum Web browser of Microsoft Internet Explorer 5.5 or higher, Mozilla Firefox 1.0 or higher, or another compatible Web browser.
If you are not sure of the version of your browser, select Help in the menu bar of your browser, then select About.
PC UsersMacintosh Users
Compatible Web browsers include Firefox (Outside Source) and Apple Safari
Illustration
Abdominal/pelvic computed tomography scans reveal innumerable low-density lesions with rim enhancement throughout the liver, consistent with metastases (pretreatment), and resolution of enhancing hepatic lesions (posttreatment).
Disclaimer
The views and opinions expressed in this activity are those of the authors and do not necessarily reflect the views of the sponsor, supporter, or publisher. Although great care has been taken in compiling and checking the information given in this activity to ensure accuracy, the authors, and Physicians' Education Resource and its servants or agents shall not be responsible or in any way liable for the continued currency of the information or for any errors, omissions, or inaccuracies in this activity, whether arising from negligence or otherwise howsoever or for any consequences arising therefrom.
Please consult full prescribing information for any drugs or procedures discussed within.
Privacy Policy
Physicians' Education Resource (PER) makes reasonable efforts to ensure that privacy issues are handled responsibly. PER does not sell or share your information with other organizations that are not directly involved in this process. If you have further concerns, you may contact us at (888) 949–0045.
All rights reserved. No part of this activity may be translated, reproduced, stored, or transmitted by any means or in any type of media form including electronic, mechanical photocopying, recording, broadcasting, or otherwise without prior permission from the publisher.
©Copyright 2008 by Physicians' Education Resource. No material may be reproduced in whole or in part, in any form, without written permission from the publisher.
All correspondence should be directed to:
Editor, Case Studies in Breast Cancer
Physicians' Education Resource
3500 Maple Ave.
Suite 700
Dallas, TX 75219
Phone: (214) 367–3456
Fax: (214) 367–3304
E–mail: editor@pergrouplp.com